Bristol Myers ends blood cancer drug deal with cell therapy maker Cellares - Reuters
Bristol Myers ends blood cancer drug deal with cell therapy maker Cellares Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxQblFOZVZ1VkVaUFlZTURQRmJGMFpQNnhBTjRmWGlXU3M0ekx1UEoxUFFhNGxic3EzOFNtTTVCNE9DeU4xakhsQWVZZUhWNkdnUmIxakF5TlZiN1VsLTVYTTlMbllsZXBMYTJFM2lDdDhONVV3NWVlSWp1dHB5N25hQXRfYjZBTHRWeG5tUjBHYnQ1QWU3WFRSOFEwODVhazV6NXRfLTZJTmNPN19iTG9KcjVMREl5UWpwN01vekVacGNleVJtclE?oc=5" target="_blank">Bristol Myers ends blood cancer drug deal with cell therapy maker Cellares</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
GSK scores regulatory wins for chronic hepatitis B drug, cancer therapy - Reuters
GSK scores regulatory wins for chronic hepatitis B drug, cancer therapy Reuters
August 24, 2026 at 07:11 AMSuccess after a century of failures: Inside Moderna and Merck's cancer vaccine breakthrough - Reuters
Success after a century of failures: Inside Moderna and Merck's cancer vaccine breakthrough Reuters
August 28, 2026 at 11:32 AMRevolution's lifesaving pancreatic cancer drug wins speedy FDA approval - Reuters
Revolution's lifesaving pancreatic cancer drug wins speedy FDA approval Reuters
August 26, 2026 at 06:18 PMBioNTech halts mRNA colorectal cancer vaccine trial after safety review - Reuters
BioNTech halts mRNA colorectal cancer vaccine trial after safety review Reuters
August 28, 2026 at 05:12 PMUS FDA expands approval for J&J's drug for rare blood disorder - Reuters
US FDA expands approval for J&J's drug for rare blood disorder Reuters
August 24, 2026 at 10:49 PMRoche, Eli Lilly's Alzheimer's blood test gets FDA clearance - Reuters
Roche, Eli Lilly's Alzheimer's blood test gets FDA clearance Reuters
August 24, 2026 at 05:39 PM